Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atrial fibrillation and anticoagulation.

L F Garnier1, Ph Rouesnel, F Espitalier

  • 1Service de cardiologie, Centre hospitalier, Vendôme.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|July 13, 2005
PubMed
Summary

Atrial fibrillation (AF) stroke risk is reduced by anticoagulants like warfarin, but bleeding is a concern. New drugs like ximelagatran offer similar efficacy with fewer bleeds, improving stroke prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3-year overall survival benefit of systematic follow-up with 18F-FDG PET/CT in asymptomatic patients treated for head and neck squamous cell carcinoma: a multicenter study.

European journal of nuclear medicine and molecular imaging·2025
Same author

Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer.

Pharmaceutical development and technology·2023
Same author

Peripheral neck nerve tumor: A 73-case study and literature review.

European annals of otorhinolaryngology, head and neck diseases·2019
Same author

Nephrogenic diabetes insipidus associated with prolonged sedation with sevoflurane in the intensive care unit.

British journal of anaesthesia·2019
Same author

Intraoperative bacterial analysis in nasal polyposis: Clinical and functional impact.

European annals of otorhinolaryngology, head and neck diseases·2019
Same author

Pressurised metered-dose inhaler for beta-2 agonist delivery during intraoperative bronchospasm: comparison of different administration methods.

British journal of anaesthesia·2019

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Atrial fibrillation (AF) significantly elevates ischemic stroke risk via left atrial thrombus formation.
  • Anticoagulant therapy, primarily warfarin, reduces embolic events but increases bleeding, especially in the elderly, leading to underuse.
  • Aspirin's efficacy in lone AF is less certain, potentially suitable for younger patients with low embolic risk.

Purpose of the Study:

  • To review current anticoagulant strategies for stroke prevention in atrial fibrillation.
  • To compare the efficacy and safety of various anticoagulant options.
  • To emphasize individualized treatment decisions based on benefit-risk assessment.

Main Methods:

  • Review of existing literature on anticoagulant therapies for atrial fibrillation.
  • Comparison of warfarin, aspirin, and newer agents like ximelagatran.
  • Consideration of urgent cardioversion protocols.

Main Results:

  • Warfarin effectively reduces stroke risk but carries a bleeding risk.
  • Low-dose aspirin may be an option for select patients, but combination with warfarin is contraindicated.
  • Ximelagatran shows promise as an effective alternative to warfarin with a better bleeding profile.
  • Intravenous unfractionated heparin is standard for urgent cardioversion; LMWH with TEE is an alternative approach.

Conclusions:

  • Treatment decisions for AF patients must be individualized based on a careful benefit-risk ratio.
  • Emerging anticoagulants like ximelagatran may offer improved safety profiles.
  • Optimizing anticoagulant use in AF remains crucial for stroke prevention.

Related Experiment Videos